New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives.

Ramon Andrade Bezerra De Mello Nathália Moisés NevesHakaru TadokoroGiovanna Araújo AmaralPedro Castelo-BrancoVictor André de Almeida Zia

Published in: Journal of clinical medicine (2020)

Challenges in NSCLC treatment include resistance to 3rd generation TKIs, the high cost of ALK inhibitors, and the need for further research on new drugs.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
small cell lung cancer
tyrosine kinase
combination therapy
replacement therapy
brain metastases